statistical software medcalc version 11.2 (MedCalc Software Ltd)
90
Structured Review
MedCalc Software Ltd
statistical software medcalc version 11.2
Statistical Software Medcalc Version 11.2, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/11%2E2+version+medcalc+statistical+software/medcalc+9+0+1/pmc04602278-159-21-20
Average 90 stars, based on 1 article reviews
Statistical Software Medcalc Version 11.2, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/11%2E2+version+medcalc+statistical+software/medcalc+9+0+1/pmc04602278-159-21-20
Average 90 stars, based on 1 article reviews
statistical software medcalc version 11.2 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Software:Article Title: Medium on-treatment platelet reactivity to ADP is favorable in patients with acute coronary syndromes undergoing coronary stenting. Article Snippet: Bleeding in the setting of acute coronary syndromes (ACS) has negative prognostic implications.. We sought to determine the impact of different levels of on-treatment platelet reactivity (PR) to ADP on both bleeding and ischemic events in ACS patients receiving coronary stenting.. PR to ADP was measured with the VerifyNow P2Y12 assay (Accumetrics, San Diego, CA) in 374 patients with ACS receiving standard dual antiplatelet therapy. |